Advances and challenges in immunotherapy in head and neck cancer

Advances and challenges in immunotherapy in head and neck cancer

Head and neck squamous cell carcinoma (HNSCC) remains a challenging malignancy with suboptimal survival outcomes despite advances in surgery, radiotherapy, and chemotherapy. Immunotherapy, particularly immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1)/programmed ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Hazem Aboaid, Taimur Khalid, Abbas Hussain, Yin Mon Myat, Rishi Kumar Nanda, Ramaditya Srinivasmurthy, Kevin Nguyen, Daniel Thomas Jones, Jo–Lawrence Bigcas, Kyaw Zin Thein
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
immunotherapy
radiotherapy
chemoradiotherapy
head and neck squamous cell carcinoma
locally advanced
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1596583/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1596583/full

Similar Items